The antineutrophil cytoplasmic antibody–associated vasculitides
Top Cited Papers
- 1 July 2004
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 117 (1) , 39-50
- https://doi.org/10.1016/j.amjmed.2004.02.030
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Design of the Wegener's Granulomatosis Etanercept Trial (WGET)Controlled Clinical Trials, 2002
- The value of pulse cyclophosphamide in ANCA‐associated vasculitis: meta‐analysis and critical reviewNephrology Dialysis Transplantation, 2001
- Proteinase 3: A cofactor for the binding of antineutrophil cytoplasm antibodies (ANCA) to endothelial cells?Kidney International, 2000
- ANCA antigens, proteinase 3 and myeloperoxidase, are not expreΔed in endothelial cellsKidney International, 2000
- Trimethoprim–Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's GranulomatosisNew England Journal of Medicine, 1996
- Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil poolFEBS Letters, 1995
- Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3Clinical and Experimental Immunology, 1995
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- Wegener Granulomatosis: An Analysis of 158 PatientsAnnals of Internal Medicine, 1992
- Anti-Neutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase in Patients with Systemic Vasculitis and Idiopathic Necrotizing and Crescentic GlomerulonephritisNew England Journal of Medicine, 1988